Vivani Says Cortigent-ClearOne Deal Awaits Final Regulatory Approval

• Vivani Medical's transaction to make its wholly owned Cortigent subsidiary a wholly owned subsidiary of ClearOne remains pending final regulatory approval.
• Closing had been anticipated in October 2026. The parties now expect completion shortly following receipt of approval.
• Under the previously disclosed agreement, Cortigent will merge with and into ClearOne's CLRO Merger Sub.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001753926-26-002036), on October 30, 2026, and is solely responsible for the information contained therein.